Loading…
CIK 0002013410 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("fcpm-iii-services-b-v","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | $24.6M | 3.2%Prev: 5.3% | 3,468,430 SH | Decreased+16,100 SH |
| CRESCENT BIOPHARMA INC. | COM | $19.9M | 2.6% | 1,677,852 SH | New |
| DYNE THERAPEUTICS INC | COM | $106.9M | 14.0%Prev: 13.8% | 5,462,846 SH | Increased |
| ENGENE HOLDINGS INC | COM | $87.0M | 11.4%Prev: 13.1% | 9,632,561 SH | Increased |
| ENGENE HOLDINGS INC | W EXP 10/31/2028 | $8.5M | 1.1%Prev: 0.4% | 2,878,148 SH | Increased |
| MAPLIGHT THERAPEUTICS INC | COM | $56.7M | 7.4% | 3,226,400 SH | New |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $322.7M | 42.3%Prev: 52.4% | 9,198,900 SH | Increased-13,484 SH |
| RAPT THERAPEUTICS INC | COM NEW | $62.1M | 8.1%Prev: 1.8% | 1,833,333 SH | Increased+1,489,096 SH |
| REPLIMUNE GROUP INC | COM | $27.3M | 3.6%Prev: 3.5% | 2,808,368 SH | Increased-1,350,000 SH |
| VOR BIOPHARMA INC | COM NEW | $47.3M | 6.2%Prev: 3.7% | 3,617,354 SH | Increased+3,237,714 SH |
| 13F-HR |
| 0001193125-26-350207 |
| $750.4M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000950123-25-008060 | $369.2M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001193125-26-225423 | $722.2M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000950123-25-005517 | $413.7M | View |